Answers are grounded in this paper and cite their sources.
Background Osteoarthritis (OA) is a leading cause of disability worldwide, yet no disease-modifying therapies are approved. Inflammatory stress disrupts chondrocyte metabolism and extracellular matrix homeostasis, contributing to cartilage degeneration. Mesenchymal stem cell (MSC)-derived extracellular vesicles (EVs) are promising cell-free therapeutics, but whether their metabolic and chondroprotective effects differ by MSC tissue source remains poorly defined. We compared the molecular cargo and biological effects of EVs from adipose tissue, bone marrow and umbilical cord MSCs (AT-EVs, BM-EVs and UC-EVs) in in vitro and ex vivo OA models. Methods EVs were isolated by differential ultracentrifugation and characterised by nanoparticle tracking analysis, transmission and cryo-transmission electron microscopy and western blotting. Chondrocyte uptake was confirmed by PKH26 labelling. In interleukin-1β (IL-1β)-stimulated human articular chondrocytes and bovine cartilage explants, we assessed proliferation, migration, cell death, senescence, matrix homeostasis, inflammatory responses and cellular bioenergetics. Quantitative proteomics and pathway-enrichment analyses identified shared and source-specific protein signatures. Results EVs from all three sources showed comparable size distributions, morphology and chondrocyte internalisation, and expressed canonical EV markers. All three EV groups promoted chondrocyte proliferation and migration and reduced cell death and catabolic and inflammatory gene expression. AT-EVs produced greater reductions in p21 and stronger pro-anabolic responses than BM-EVs and UC-EVs, the greatest increase in basal respiration, and were the only EV group to increase glycolysis relative to IL-1β alone. The 817 proteins shared across EV groups were enriched in glycolysis and PI3K–AKT signalling, whereas candidate proteins more abundant in AT-EVs were enriched for extracellular matrix organisation relative to BM-EVs and UC-EVs, and for carbohydrate metabolism relative to UC-EVs. AT-EVs also restored PTEN phosphorylation and suppressed IL-1β-induced AKT and mTOR phosphorylation more effectively than BM-EVs and UC-EVs. Conclusions MSC-derived EVs show source-dependent molecular and functional heterogeneity in OA models. AT-EVs showed the most consistent metabolic and chondroprotective activity under the conditions tested. However, each MSC source was represented by a single donor-derived product, limiting attribution of these differences to tissue source. Validation across independent MSC donors under controlled production and dosing conditions, and in animal models of OA, will establish their broader relevance and therapeutic potential.
No takes yet. Share an insight, caveat, or question.
Mei et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: